Literature DB >> 9504959

Skeletal alkaline phosphatase activity is primarily released from human osteoblasts in an insoluble form, and the net release is inhibited by calcium and skeletal growth factors.

D J Anh1, H P Dimai, S L Hall, J R Farley.   

Abstract

Skeletal alkaline phosphatase (ALP) is anchored to membrane inositol-phosphate on the outer surface of osteoblasts. Although skeletal ALP activity in serum is, essentially, all in an anchorless (soluble) form, in vitro studies indicate that ALP can be released in either an anchorless, soluble form (e.g., by a phospholipase) or an anchor-intact, insoluble form (e.g., by vesicle exocytosis). The current studies were intended to define the contributions of each of these putative processes of ALP release and to assess the significance of regulation by calcium (Ca) and skeletal effectors. ALP activity was measured in serum-free medium from replicate cultures of human osteosarcoma (SaOS-2) cells and normal human bone cells. Temperature-sensitive phase distribution (in Triton X-114) allowed separation of soluble from insoluble ALP activity. Our studies revealed that most of the ALP activity released from SaOS-2 cells was in an insoluble form (78% +/- 8%), a percentage that was constant between 2 and 96 hours. A similar result was seen for normal human bone cells. Calcium had a negative, biphasic dose-dependent effect on net release of ALP activity: r = -0.85, P < 0.001 at 24 hours, with KIapparent values for biphasic inhibition of 20 and 300 mumol/l Ca. Of the skeletal effectors tested, insulin-like growth factor-II (IGF-II) had the greatest effect, decreasing the net release of ALP activity in a dose-dependent manner (r = -0.82, P < 0.005). Neither Ca nor IGF-II affected the distribution of soluble/insoluble ALP activity by more than 9%. IGF-II had no effect on extracellular ALP stability, but the addition of Ca to Ca-free cultures resulted in parallel losses of extracellular ALP activity and ALP immunoreactive protein (P < 0.001 for each). A similar effect was seen when Ca was added to Ca-free, cell-free, conditioned medium, but not when Ca was added to purified ALP, which is consistent with the general hypothesis that a Ca-dependent protease might be present in the cell-conditioned medium. Together, these data suggest that most of the ALP activity released from osteoblasts is insoluble (and, presumably, anchorless), net release of ALP activity is negatively regulated by Ca and skeletal growth factors, the effect of Ca may reflect Ca-dependent protease activity, and an exogenous (e.g., serum) phospholipase may be responsible for releasing ALP from its insoluble anchor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504959     DOI: 10.1007/s002239900441

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  11 in total

1.  Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.

Authors:  Cecilia Halling Linder; Sonoko Narisawa; José Luis Millán; Per Magnusson
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

2.  A tissue engineering approach for periodontal regeneration based on a biodegradable double-layer scaffold and adipose-derived stem cells.

Authors:  João F Requicha; Carlos A Viegas; Fernando Muñoz; Jorge M Azevedo; Isabel B Leonor; Rui L Reis; Manuela E Gomes
Journal:  Tissue Eng Part A       Date:  2014-04-22       Impact factor: 3.845

3.  Osteoblast differentiation and migration are regulated by dynamin GTPase activity.

Authors:  Pierre P Eleniste; Su Huang; Kornchanok Wayakanon; Heather W Largura; Angela Bruzzaniti
Journal:  Int J Biochem Cell Biol       Date:  2013-10-26       Impact factor: 5.085

4.  Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones.

Authors:  Melita M Dvorak; Ashia Siddiqua; Donald T Ward; D Howard Carter; Sarah L Dallas; Edward F Nemeth; Daniela Riccardi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

5.  Development of an ELISA method for detecting immune complexes between tissue-nonspecific alkaline phosphatase and immunoglobulin G.

Authors:  Kazuo Hocchi; Tatsuya Ohashi; Toshihide Miura; Kumiko Sasagawa; Yasuhito Sato; Fumio Nomura; Takeshi Tomonaga; Masahiko Sunaga; Ryo Kojima; Katsuhiro Katayama; Toshiyuki Kato; Toyoji Sato; Tsugikazu Komoda; Kimimitsu Oda
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

6.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

7.  A Study of the Effects of Doxorubicin-Containing Liposomes on Osteogenesis of 3D Stem Cell Spheroids Derived from Gingiva.

Authors:  Hyunjin Lee; Jihwan Son; Sae Kyung Min; Chae-Bin Na; Gawon Yi; Heebeom Koo; Jun-Beom Park
Journal:  Materials (Basel)       Date:  2019-08-23       Impact factor: 3.623

Review 8.  Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.

Authors:  Mathias Haarhaus; Dean Gilham; Ewelina Kulikowski; Per Magnusson; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

Review 9.  The Regulation of Collagen Processing by miRNAs in Disease and Possible Implications for Bone Turnover.

Authors:  Tomasz P Lehmann; Urszula Guderska; Klaudia Kałek; Maria Marzec; Agnieszka Urbanek; Alicja Czernikiewicz; Maria Sąsiadek; Paweł Karpiński; Andrzej Pławski; Maciej Głowacki; Paweł P Jagodziński
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

10.  The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.

Authors:  Mathias Haarhaus; Anders Fernström; Abdul Rashid Qureshi; Per Magnusson
Journal:  Nutrients       Date:  2021-12-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.